AAAAAA
Results: 1-25/49
Authors:
CAPELL HA
MAIDEN N
MADHOK R
HAMPSON R
THOMSON EA
Citation: Ha. Capell et al., INTENTION-TO-TREAT ANALYSIS OF 200 PATIENTS WITH RHEUMATOID-ARTHRITIS12 YEARS AFTER RANDOM ALLOCATION TO EITHER SULFASALAZINE OR PENICILLAMINE, Journal of rheumatology, 25(10), 1998, pp. 1880-1886
Authors:
BLACK AJ
MCLEOD HL
CAPELL HA
POWRIE RH
MATOWE LK
PRITCHARD SC
COLLIEDUGUID ESR
REID DM
Citation: Aj. Black et al., THIOPURINE METHYLTRANSFERASE GENOTYPE PREDICTS THERAPY-LIMITING SEVERE TOXICITY FROM AZATHIOPRINE, Annals of internal medicine, 129(9), 1998, pp. 716-718
Authors:
MUNRO R
CAPELL HA
Citation: R. Munro et Ha. Capell, DISEASE-MODIFYING DRUGS SERIES - PENICILLAMINE, British journal of rheumatology, 36(1), 1997, pp. 104-109
Authors:
MUNRO R
MADHOK R
THOMSON EA
CAPELL HA
Citation: R. Munro et al., THE DEGREE OF FUNCTIONAL IMPROVEMENT OVER 5 YEARS OF IM GOLD DEPENDS ON INITIAL DISEASE DURATION, Arthritis and rheumatism, 40(9), 1997, pp. 128-128
Authors:
MAIDEN N
CAPELL HA
MADHOK R
THOMSON EA
HAMPSON R
Citation: N. Maiden et al., THE INFLUENCE OF RELATIVE POVERTY ON MORTALITY IN RA - A STUDY OF 200PATIENTS OVER 12 YEARS, Arthritis and rheumatism, 40(9), 1997, pp. 509-509
Authors:
CRILLY A
MAIDEN N
CAPELL HA
MADHOK R
Citation: A. Crilly et al., HLA DR-BETA-1 GENES AND EARLY MAJOR JOINT SURGERY IN RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 40(9), 1997, pp. 755-755
Authors:
CAPELL HA
MAIDEN N
MADHOK R
HAMPSON R
THOMSON EA
Citation: Ha. Capell et al., OUTCOME IN 200 RA PATIENTS 10 YEARS AFTER RANDOM ALLOCATION TO EITHERSULFASALAZINE OR PENICILLAMINE, Arthritis and rheumatism, 40(9), 1997, pp. 966-966
Authors:
CAPELL HA
GORDON MM
PORTER D
Citation: Ha. Capell et al., DOES SULFASALAZINE (SASP) CAUSE DRUG-INDUCED SLE - EVIDENCE FROM A PROSPECTIVE RANDOMIZED TRIAL OF 200 RHEUMATOID (RA) PATIENTS TREATED WITH SASP OR AURANOFIN (AUR) OVER 5 YEARS, Arthritis and rheumatism, 40(9), 1997, pp. 967-967
Authors:
CAPELL HA
MORRISON E
MCENTEGART A
MAIDEN N
MADHOK R
HAMPSON R
THOMSON EA
Citation: Ha. Capell et al., RHEUMATOID-ARTHRITIS (RA) - INFLUENCE OF SOCIAL DISADVANTAGE ON FUNCTION, Arthritis and rheumatism, 40(9), 1997, pp. 1552-1552
Authors:
MCENTEGART A
MORRISON E
CAPELL HA
DUNCAN MR
PORTER D
MADHOK R
THOMSON EA
Citation: A. Mcentegart et al., EFFECT OF SOCIAL DEPRIVATION ON DISEASE SEVERITY AND OUTCOME IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Annals of the Rheumatic Diseases, 56(7), 1997, pp. 410-413
Authors:
MUNRO R
MORRISON E
MCDONALD AG
HUNTER JA
MADHOK R
CAPELL HA
Citation: R. Munro et al., EFFECT OF DISEASE-MODIFYING AGENTS ON THE LIPID PROFILES OF PATIENTS WITH RHEUMATOID-ARTHRITIS, Annals of the Rheumatic Diseases, 56(6), 1997, pp. 374-377
Authors:
DUNCAN MR
CAPELL HA
Citation: Mr. Duncan et Ha. Capell, THE USE OF ANTIMALARIALS IN COMBINATION WITH OTHER DISEASE-MODIFYING AGENTS IN RA - THE BRITISH-EXPERIENCE, Lupus, 5, 1996, pp. 50-58
Authors:
MCENTEGART A
PORTER D
CAPELL HA
THOMSON EA
Citation: A. Mcentegart et al., SULFASALAZINE HAS A BETTER EFFICACY TOXICITY PROFILE THAN AURANOFIN -EVIDENCE FROM A 5-YEAR PROSPECTIVE, RANDOMIZED TRIAL/, Journal of rheumatology, 23(11), 1996, pp. 1887-1890
Authors:
MUNRO R
DUNCAN M
CAPELL HA
JOHNSTON R
Citation: R. Munro et al., UNUSUAL COMPLICATIONS OF CERVICAL-SPINE SURGERY FOR CERVICAL MYELOPATHY IN RHEUMATOID-ARTHRITIS, British journal of rheumatology, 35(7), 1996, pp. 682-685
Authors:
PORTER DR
CAPELL HA
MCINNES I
MUNRO R
MADHOK R
HUNTER JA
THOMSON EA
Citation: Dr. Porter et al., IS RHEUMATOID-ARTHRITIS BECOMING A MILDER DISEASE - OR ARE WE STARTING 2ND-LINE THERAPY IN PATIENTS WITH MILDER DISEASE, British journal of rheumatology, 35(12), 1996, pp. 1305-1308
Authors:
MORRIS AJ
LEE FD
CAPELL HA
MCKENZIE JF
STURROCK RD
Citation: Aj. Morris et al., JEJUNAL LESIONS IN ANKYLOSING-SPONDYLITIS ARE DUE TO NONSTEROIDAL ANTIINFLAMMATORY DRUG-THERAPY, Arthritis and rheumatism, 39(9), 1996, pp. 1070-1070
Authors:
MCINNES IB
PORTER D
MURPHY EA
THOMSON EA
MADHOK R
HUNTER JA
PULLAR T
CAPELL HA
Citation: Ib. Mcinnes et al., LOW-DOSE DESENSITIZATION DOES NOT REDUCE THE TOXICITY OF SULFASALAZINE IN RHEUMATOID-ARTHRITIS, Annals of the Rheumatic Diseases, 55(5), 1996, pp. 328-330
Authors:
CRILLY A
CAPELL HA
WATSON J
MADHOK R
Citation: A. Crilly et al., THE EFFECT OF AURANOFIN AND SULFASALAZINE THERAPY ON CIRCULATING LEVELS OF INTERLEUKIN-6 IN RHEUMATOID-ARTHRITIS PATIENTS, Clinical rheumatology, 14(5), 1995, pp. 561-565
Authors:
CRILLY A
MCINNESS IB
MCDONALD AG
WATSON J
CAPELL HA
MADHOK R
Citation: A. Crilly et al., INTERLEUKIN-6 (IL-6) AND SOLUBLE IL-2 RECEPTOR LEVELS IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED WITH LOW-DOSE ORAL METHOTREXATE, Journal of rheumatology, 22(2), 1995, pp. 224-226
Authors:
CAPELL HA
Citation: Ha. Capell, CLINICAL EFFICACY OF SULFASALAZINE - A REVIEW, British journal of rheumatology, 34, 1995, pp. 35-39
Authors:
MCINNES IB
CAPELL HA
Citation: Ib. Mcinnes et Ha. Capell, MANAGEMENT OF RHEUMATOID-ARTHRITIS, Scottish Medical Journal, 40(2), 1995, pp. 35-36
Authors:
MORRIS AJ
CANVIN J
CAPELL HA
STURROCK RD
MACKENZIE JF
GEMMELL CG
RUSSELL RI
Citation: Aj. Morris et al., JEJUNAL BACTERIA IN ARTHRITIS - IMPORTANT IN PATHOGENESIS OF DISEASE OR DEVELOPMENT OF NSAID ENTEROPATHY, Gastroenterology, 108(4), 1995, pp. 879-879
Authors:
MORRIS AJ
POTTER U
CAPELL HA
STURROCK RD
LEE FD
COLLINS T
MACKENZIE JF
Citation: Aj. Morris et al., JEJUNAL LESIONS IN HUMAN NONSTEROIDAL ANTIINFLAMMATORY DRUG (NSAID) ENTEROPATHY, Gastroenterology, 108(4), 1995, pp. 879-879
Authors:
MUNRO R
MORRISON E
MACDONALD A
THOMSON EA
MADHOK R
HUNTER JA
CAPELL HA
Citation: R. Munro et al., LIPID PROFILE IN RA PATIENTS - A COMPARITIVE STUDY OF HYDROXYCHLOROQUINE AND IM GOLD SUGGESTS A PROTECTIVE EFFECT FROM ANTIMALARIALS, Arthritis and rheumatism, 38(9), 1995, pp. 661-661
Authors:
MCENTEGART A
PORTER D
CAPELL HA
MADHOK R
HUNTER JA
THOMSON EA
Citation: A. Mcentegart et al., 5-YEAR PROSPECTIVE-STUDY OF 200 RA PATIENTS ON SULFASALAZINE (SASP) OR AURANOFIN (AUR), Arthritis and rheumatism, 38(9), 1995, pp. 1294-1294